{
    "2021-09-08": [
        [
            {
                "time": "",
                "original_text": "恒瑞医药与天广实达成第三代CD20抗体MIL62的商业化合作，3000万美元参与其港股IPO基石投资",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "天广实",
                        "CD20抗体",
                        "商业化合作",
                        "港股IPO",
                        "基石投资"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "北向资金结束连续12日净买入，中国平安、歌尔股份净卖出均超6亿元",
                "features": {
                    "keywords": [
                        "北向资金",
                        "净买入",
                        "中国平安",
                        "歌尔股份",
                        "净卖出"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融",
                        "电子"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业2021年中报总结：创新投入力度持续增强 CXO、消费医疗和生物制品增长更快",
                "features": {
                    "keywords": [
                        "医药生物",
                        "创新投入",
                        "CXO",
                        "消费医疗",
                        "生物制品",
                        "增长"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2021-09-07",
                "original_text": "A股融资融券日报：两融余额增加100.34亿元（9月7日）",
                "features": {
                    "keywords": [
                        "A股",
                        "融资融券",
                        "两融余额",
                        "增加"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}